Bipolar disorder is a heritable mental illness with complex etiology. We performed a genome-wide
association study of 41,917 bipolar disorder cases and 371,549 controls of European …

The field of pharmacogenomics (PGx) is gradually shifting from the reactive testing of single
genes toward the proactive testing of multiple genes to improve treatment outcomes, reduce …

Hypersensitivity reactions to drugs are often unpredictable and can be life threatening,
underscoring a need for understanding their underlying mechanisms and risk factors. The extent …

Hearing loss is one of the top contributors to years lived with disability and is a risk factor for
dementia. Molecular evidence on the cellular origins of hearing loss in humans is growing. …

Inhibition of sclerostin is a therapeutic approach to lowering fracture risk in patients with
osteoporosis. However, data from phase 3 randomized controlled trials (RCTs) of romosozumab, …

Previous genome-wide association studies (GWASs) of stroke — the second leading cause
of death worldwide — were conducted predominantly in populations of European ancestry 1 …

Pharmacogenomics aims to tailor pharmacological treatment to each individual by considering
associations between genetic polymorphisms and adverse drug effects (ADEs). With …

Post-traumatic stress disorder (PTSD) genetics are characterized by lower discoverability
than most other psychiatric disorders. The contribution to biological understanding from …

Understanding factors associated with COVID-19 vaccination can highlight issues in public
health systems. Using machine learning, we considered the effects of 2,890 health, socio-…

Purpose Biomedical databases combining electronic medical records and phenotypic and
genomic data constitute a powerful resource for the personalization of treatment. To leverage …